Condition
Sudden Sensorineural Hearing Loss (SSNHL)
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Not Yet Recruiting4
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07134075Phase 2Not Yet RecruitingPrimary
Intracochlear Injection of Glucocorticoid
NCT06997406Not ApplicableNot Yet RecruitingPrimary
'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss
NCT06819202Not Yet RecruitingPrimary
Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function
NCT06878599Phase 4Not Yet RecruitingPrimary
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
NCT03255473Phase 2WithdrawnPrimary
High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
Showing all 5 trials